BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35621688)

  • 21. Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy.
    Watari H; Mitamura T; Moriwaki M; Hosaka M; Ohba Y; Sudo S; Todo Y; Takeda M; Ebina Y; Sakuragi N
    Int J Gynecol Cancer; 2009 Dec; 19(9):1585-90. PubMed ID: 19955942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
    Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
    Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy.
    Kimmig R; Iannaccone A; Aktas B; Buderath P; Heubner M
    Arch Gynecol Obstet; 2016 Jul; 294(1):153-60. PubMed ID: 26596725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy.
    Otsuka I; Kubota T; Aso T
    Br J Cancer; 2002 Aug; 87(4):377-80. PubMed ID: 12177772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
    Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
    Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
    Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
    BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of outcome of Stage I-III endometrial cancer treated with systematic operation omitting paraaortic lymphadenectomy.
    Kyo S; Hashimoto M; Maida Y; Mizumoto Y; Nakamura M; Takakura M; Inoue M
    Eur J Gynaecol Oncol; 2007; 28(3):170-3. PubMed ID: 17624080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy.
    Pendlebury A; Radeva M; Rose PG
    J Surg Oncol; 2021 Apr; 123(5):1292-1298. PubMed ID: 33592112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
    Seagle BL; Kocherginsky M; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
    Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
    BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of lymph nodes in endometrioid uterine cancer.
    Delpech Y; Barranger E
    Curr Opin Oncol; 2010 Sep; 22(5):487-91. PubMed ID: 20531186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma.
    Pakish J; Soliman PT; Frumovitz M; Westin SN; Schmeler KM; Reis RD; Munsell MF; Ramirez PT
    Gynecol Oncol; 2014 Feb; 132(2):366-71. PubMed ID: 24361579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():239-246. PubMed ID: 34247041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.
    ; Kitchener H; Swart AM; Qian Q; Amos C; Parmar MK
    Lancet; 2009 Jan; 373(9658):125-36. PubMed ID: 19070889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - A population-based cohort study.
    Åkesson Å; Adok C; Dahm-Kähler P
    Eur J Cancer; 2022 Jul; 169():54-63. PubMed ID: 35500461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.